Clinical Chemistry
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 27: 692-696, 1981;
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ahlfors, C. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ahlfors, C. E.

Clinical Chemistry, Vol 27, 692-696, Copyright © 1981 by American Association for Clinical Chemistry

Effect of serum dilution on apparent unbound bilirubin concentration as measured by the peroxidase method

CE Ahlfors

I studied the effects of serum dilution and oxidation of albumin-bound bilirubin on the accuracy of results by the peroxidase method for assessing bilirubin-albumin binding. The apparent concentration of unbound bilirubin decreases with dilution of bilirubin-enriched serum or defatted-albumin solutions, the effect being more marked with serum. The decrease in apparent unbound bilirubin does not appear to be due to slow oxidation of albumin-bound bilirubin. Instead, the bilirubin- albumin complex has a much lower apparent dissociation rate constant (K- 1) in serum (0.0033 [SD 0.0002] s-1) than in solutions of defatted- albumin (0.017 [SD 0.006] s-1), causing the dissociation of the complex to be rate-limiting when serum is analyzed at the currently recommended 40-fold dilution and peroxidase concentration (0.11 mu mol/L). In addition, dilution appears to enhance bilirubin binding by serum but not by defatted-albumin solutions. Decreasing the serum dilution and peroxidase concentration may significantly improve the accuracy of the peroxidase test. The actual correlation between clinical bilirubin toxicity and specific unbound bilirubin concentrations, however, remains to be determined.


The following articles in journals at HighWire Press have cited this article:


Home page
 PediatricsHome page
A. F. McDonagh, H. J. Vreman, R. J. Wong, and D. K. Stevenson
Photoisomers: Obfuscating Factors in Clinical Peroxidase Measurements of Unbound Bilirubin?
Pediatrics, January 1, 2009; 123(1): 67 - 76.
[Abstract] [Full Text] [PDF]

Home page
 PediatricsHome page
R. P. Wennberg, C. E. Ahlfors, V. K. Bhutani, L. H. Johnson, and S. M. Shapiro
Toward Understanding Kernicterus: A Challenge to Improve the Management of Jaundiced Newborns
Pediatrics, February 1, 2006; 117(2): 474 - 485.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
R. A. Weisiger, J. D. Ostrow, R. K. Koehler, C. C. Webster, P. Mukerjee, L. Pascolo, and C. Tiribelli
Affinity of Human Serum Albumin for Bilirubin Varies with Albumin Concentration and Buffer Composition. RESULTS OF A NOVEL ULTRAFILTRATION METHOD
J. Biol. Chem., August 3, 2001; 276(32): 29953 - 29960.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1981 by the American Association for Clinical Chemistry.